1 completed, 1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow AL-S Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate, Safety, Tolerability, and PK of AP-101 in Participants With ALS AP-101, Placebo - Amyotrophic Lateral Sclerosis | Phase 2 | Completed | AL-S Pharma | 73 | 2021-09-02 | 2026-09-30 |
| A Study to Evaluate AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS) AP-101 - Amyotrophic Lateral Sclerosis | Phase 1 | Unknown | AL-S Pharma | 18 | 2019-10-10 | 2020-10-27 |
Amyotrophic Lateral Sclerosis (2) · Amyotrophic lateral sclerosis 1 (2)
Canada (2) · Belgium (1) · Germany (1) · South Korea (1) · Sweden (1) · United States (1)